Back to Stakeholders
Categories

2 domains / 5 areas / 4 specializations

Adjunct Industries
Adjunct Industries
Technology, Data, & Software PlatformsDigital Therapeutics
Care Delivery & Psychedelic Facilitation
Care Delivery & Psychedelic Facilitation
Clinical Care Delivery OrganizationsSpecialty & Outpatient ClinicsVirtual & Hybrid Care Providers
Practitioner-Led Care OrganizationsFacilitation Provider Organizations

Mindbloom

Data updated

New York, United States
1 Paper

Ketamine therapy platform combining telehealth, digital treatment flow, and app-guided support for depression and related mental health conditions.

Clinical Care Delivery Snapshot

Specialty & Outpatient Clinics

Provider Model

Multi-Model Organization

Organization Status

Unknown

Psychedelic Services

Ketamine-Only Services

Service Coverage

1 country

Service Profile

Care Settings

Specialty Outpatient ClinicTelehealth / VirtualMixed SettingsHome-Supported Care

Service Modalities

Ketamine Infusion TherapyKetamine-Assisted Psychotherapy (KAP)Psychedelic Integration-Only Services

Payer Models

Unknown

Service Coverage Countries

United States

Non-Psychedelic Service Mix

Unknown

Visit Provider

Care Delivery Notes

Seeded from user-provided care-delivery.xlsx list. Contacts: Dylan Beynon (CEO) Contact emails: support@mindbloom.com Contact phones: 1-800-273-9255

Sources

Official website

https://www.mindbloom.com/

Mindbloom - Home

https://www.mindbloom.com/

Practitioner-Led Care Snapshot

Organization Model

Not set

Organization Status

Not set

Psychedelic Services

Active Psychedelic-Related Offering

Service Coverage

Coverage not set

Care Profile

Care Modalities

Preparation & Integration Sessions
Visit Provider

Sources

Official website

https://www.mindbloom.com/

Technology, Data, & Software Snapshot

Digital Therapeutics

Platform Model

Digital Therapeutics Product

Deployment

SaaS Application

Geography

National

Coverage

1 country

Customer Types

Patient / Consumer PopulationsClinical Providers / Networks

Capability Focus Areas

Digital Care Pathways

Data Modalities

Patient-Reported OutcomesBehavioral / Survey Data

Technology Notes

Mindbloom operates a software-enabled ketamine care pathway with psychedelic-adjacent digital therapeutic support.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Last Verified

Apr 9, 2026

Primary Platform Link

Source Evidence

Mindbloom - Homepage

https://www.mindbloom.com/

Mindbloom Article - 5 Ways Ketamine Therapy Rewires Your Brain

https://www.mindbloom.com/5-ways-ketamine-therapy-rewires-your-brain

Quick Facts

HQ
New York, United States
Website
Visit

Research Papers

1
Open Accessindividual

At-Home Telehealth-Supported Subcutaneous Ketamine Therapy in Adults With Moderate to Severe Depression, Anxiety, or PTSD: A Real-World Observational Study of Safety, Feasibility, and Clinical Outcomes in a Large, Heterogeneous Cohort in the United States

This retrospective observational study (n=3,870) examined telehealth-supported at-home subcutaneous ketamine for adults with moderate to severe depression, anxiety or PTSD and found large reductions in symptom scores over six sessions, with most patients reaching a clinically meaningful improvement. Adverse events were uncommon and no serious complications related to the injections were reported.

Published
Journal
Journal of Medical Internet Research
Authors
Parks, A. C., Woodward, A. L., Henry, R. D., Arden, K. A., Vando, L., Swain, J., Lamichhane, B.